ReviewStem cell research & therapy2022

Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells.

Jiangtao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.